ANSTO to manufacture skin cancer treatment

Nuclear science and technology organisation ANSTO has been licensed as the Australian manufacturing partner of a new non-invasive treatment for non-melanoma skin cancer (NMSC). Radioisotope developer OncoBeta and ANSTO will establish local manufacturing of the company’s epidermal radioisotope therapy, Rhenium-SCT (Skin Cancer Therapy) for the treatment of non-melanoma skin cancer. ANSTO operates the OPAL nuclear…

Details

Manufacturing news briefs – stories you might have missed

Amaero International to review strategic alternatives Additive manufacturing technology company Amaero International has commissioned investment and advisory firm Guggenheim Securities to evaluate strategic alternatives for the company. The study was aimed at ensuring it was ‘taking every step possible to maximise value for shareholders’, according to an announcement. Amaero said no decisions had been made…

Details

Canberra backs steelworks, hints at further MMI investment

BlueScope Steel will invest $217 updating the Port Kembla steelworks with the assistance of a federal government Modern Manufacturing Initiative grant. Canberra will provide $55.4 million to the project which will ‘shore up the supply of Australian steel to support renewable energy projects and our local defence sector’, according to the government. Steel plate produced…

Details